Diet and apoptosis.

A range of compounds in or derived from the diet modulates apoptosis in cell cultures in vitro. These observations have important implications concerning the mechanisms whereby dietary components affect health. Proapoptotic compounds could protect against cancer by enhancing elimination of initiated, precancerous cells, and antiapoptotic compounds could promote tumor formation by inhibiting apoptosis in genetically damaged cells. Proapoptotic compounds could also contribute to age-related degenerative diseases by activating cell death in postmitotic cells or shifting the normal balance of mitosis and apoptosis in tissues with regenerative capacity. Many age-related diseases, for example macular degeneration and Parkinson's disease, appear to have oxidative stress as an underlying component that interacts with genetic, dietary, and environmental factors to determine relative risk in an individual. Oxidative stress activates apoptosis, and antioxidants protect against apoptosis in vitro; thus, a central role of dietary antioxidants may be to protect against apoptosis. However, little in vivo data are available to directly link diet with altered apoptosis as an underlying determinant of disease. Moreover, the possible antagonistic effects of different dietary components and the uncertainty about whether proapoptotic compounds that may protect against cancer could contribute to degenerative diseases and vice versa indicate that there is a great need for better in vivo assessment of apoptosis and that caution should be exercised when extrapolating in vitro data on apoptosis to in vivo dietary recommendations.

[1]  Ira Shoulson,et al.  DATATOP: A decade of neuroprotective inquiry , 1998 .

[2]  K. Shokat,et al.  Antigen-induced B-cell death and elimination during germinal-centre immune responses , 1995, Nature.

[3]  Y. Shukla,et al.  Antitumour activity of diallyl sulfide on polycyclic aromatic hydrocarbon-induced mouse skin carcinogenesis. , 1998, Cancer letters.

[4]  S. Orrenius,et al.  Genistein induces apoptosis in immature human thymocytes by inhibiting topoisomerase-II. , 1993, Biochemical and biophysical research communications.

[5]  G. Block,et al.  Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. , 1992, Nutrition and cancer.

[6]  W. Tatton,et al.  Apoptosis in neurodegenerative diseases: the role of mitochondria. , 1999, Biochimica et biophysica acta.

[7]  Jun Wang,et al.  Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. , 1998, Carcinogenesis.

[8]  Dean P. Jones,et al.  Mitochondrial control of apoptosis: the role of cytochrome c. , 1998, Biochimica et biophysica acta.

[9]  B. Björkerud,et al.  Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[10]  M. Bachmann,et al.  Selection of the T cell repertoire. , 1999, Annual review of immunology.

[11]  T. Pillot,et al.  The nonfibrillar amyloid beta-peptide induces apoptotic neuronal cell death: involvement of its C-terminal fusogenic domain. , 2002, Journal of neurochemistry.

[12]  S. Paul,et al.  Involvement of a Caspase‐3‐Like Cysteine Protease in 1‐Methyl‐4‐Phenylpyridinium‐Mediated Apoptosis of Cultured Cerebellar Granule Neurons , 1997, Journal of neurochemistry.

[13]  Y. Tamada,et al.  Apoptotic cell death in formation of vesicular skin lesions in patients with acquired zinc deficiency , 1996, Journal of cutaneous pathology.

[14]  Vitamin E consumption and the risk of coronary disease in women. , 1993 .

[15]  R D Kamm,et al.  Mechanical properties of model atherosclerotic lesion lipid pools. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[16]  S. Ripatti,et al.  Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction , 1997, The Lancet.

[17]  Xiaodong Wang,et al.  Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death Receptors , 1998, Cell.

[18]  E. Topol,et al.  Strategies to achieve coronary arterial plaque stabilization. , 1999, Cardiovascular research.

[19]  Junying Yuan,et al.  ICE, neuronal apoptosis and neurodegeneration , 1998, Cell Death and Differentiation.

[20]  Dean P. Jones,et al.  Glutathione redox potential in response to differentiation and enzyme inducers. , 1999, Free radical biology & medicine.

[21]  M. Kockx Apoptosis in the atherosclerotic plaque: quantitative and qualitative aspects. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[22]  K. G. Smith,et al.  Apoptosis and the B cell response to antigen. , 1997, International reviews of immunology.

[23]  A E Becker,et al.  Atherosclerotic plaque rupture--pathologic basis of plaque stability and instability. , 1999, Cardiovascular research.

[24]  T. Sugimura,et al.  Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell line LNCaP. , 1998, Japanese journal of clinical oncology.

[25]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[26]  R. Siegel,et al.  Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. , 1999, Annual review of immunology.

[27]  P. Zalewski,et al.  Regulation of caspase activation and apoptosis by cellular zinc fluxes and zinc deprivation: A review , 1999, Immunology and cell biology.

[28]  Dean P. Jones,et al.  Oxidative damage and protection of the RPE , 2000, Progress in Retinal and Eye Research.

[29]  J W Langston,et al.  Parkinson disease in twins: an etiologic study. , 1999, JAMA.

[30]  J. Morgenlander,et al.  Update on Alzheimer's disease: Promising advances in detection and treatment , 1999 .

[31]  P. Paty,et al.  Mitochondrial Proliferation and Paradoxical Membrane Depolarization during Terminal Differentiation and Apoptosis in a Human Colon Carcinoma Cell Line , 1997, The Journal of cell biology.

[32]  R. Schwartz,et al.  Apoptosis. Basic concepts and implications in coronary artery disease. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[33]  M. Gould,et al.  Effects of anticarcinogenic monoterpenes on phase II hepatic metabolizing enzymes. , 1993, Carcinogenesis.

[34]  Yiwei Li,et al.  Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein , 1999, Oncogene.

[35]  G. Evan,et al.  A matter of life and cell death. , 1998, Science.

[36]  K. Prasad,et al.  Multiple antioxidants in the prevention and treatment of Parkinson's disease. , 1999, Journal of the American College of Nutrition.

[37]  M. Mattson,et al.  Participation of prostate apoptosis response‐4 in degeneration of dopaminergic neurons in models of Parkinson's disease , 1999, Annals of neurology.

[38]  J. Milner,et al.  Allyl sulfides from garlic suppress the in vitro proliferation of human A549 lung tumor cells. , 1997, Nutrition and cancer.

[39]  V. Fuster,et al.  Pathophysiology and clinical significance of atherosclerotic plaque rupture. , 1999, Cardiovascular research.

[40]  C. Shaw,et al.  Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death , 1997, Brain Research Reviews.

[41]  Dean P. Jones,et al.  Variability in glutathione-dependent detoxication in vivo and its relevance to detoxication of chemical mixtures. , 1995, Toxicology.

[42]  I. Johnson,et al.  Dietary n-3 PUFA increases the apoptotic response to 1,2-dimethylhydrazine, reduces mitosis and suppresses the induction of carcinogenesis in the rat colon. , 1999, Carcinogenesis.

[43]  C. Marsden,et al.  The causes of parkinson's disease are being unraveled and rational neuroprotective therapy is close to reality , 1998, Annals of neurology.

[44]  E. Rimm,et al.  Vitamin E consumption and the risk of coronary heart disease in men. , 1993, The New England journal of medicine.

[45]  R. Burke,et al.  Programmed cell death: Does it play a role in parkinson's disease? , 1998, Annals of neurology.

[46]  O. Andreassen,et al.  Transgenic mice expressing a dominant negative mutant interleukin-1beta converting enzyme show resistance to MPTP neurotoxicity. , 1999, Neuroreport.

[47]  D. Lane,et al.  p53, guardian of the genome , 1992, Nature.

[48]  J. Mathers Nutrient regulation of intestinal proliferation and apoptosis , 1998, Proceedings of the Nutrition Society.

[49]  M. Lipkin,et al.  Dietary factors in human colorectal cancer. , 1999, Annual review of nutrition.

[50]  Yiwei Li,et al.  p53-independent apoptosis induced by genistein in lung cancer cells. , 1999, Nutrition and cancer.

[51]  F. Kelly,et al.  Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) , 1996, The Lancet.

[52]  S. Cory,et al.  The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.

[53]  Amanda Mishizen,et al.  Neurotransmitters, KCl and antioxidants rescue striatal neurons from apoptotic cell death in culture , 1999, Brain Research.

[54]  R. Faull,et al.  Apoptosis, Neurotrophic Factors and Neurodegeneration , 1997, Reviews in the neurosciences.

[55]  M. Toborek,et al.  Zinc nutrition and apoptosis of vascular endothelial cells: implications in atherosclerosis. , 1999, Nutrition.

[56]  M. Bennett Mechanisms of p53-induced apoptosis. , 1999, Biochemical pharmacology.

[57]  S. Srivastava,et al.  Mechanism of differential efficacy of garlic organosulfides in preventing benzo(a)pyrene-induced cancer in mice. , 1997, Cancer letters.

[58]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[59]  Mary J. DeLong Apoptosis: A Modulator of Cellular Homeostasis and Disease States , 1998, Annals of the New York Academy of Sciences.

[60]  J. Mehta,et al.  γ-Tocopherol Decreases Ox-LDL-Mediated Activation of Nuclear Factor-κB and Apoptosis in Human Coronary Artery Endothelial Cells , 1999 .

[61]  A. Newby,et al.  Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. , 1999, Cardiovascular research.

[62]  P. Bougnoux,et al.  n-3 polyunsaturated fatty acids and cancer. , 1999, Current opinion in clinical nutrition and metabolic care.

[63]  K. Sakamaki,et al.  The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis , 1999, Nature.

[64]  C. Oliveira,et al.  Involvement of Oxidative Stress on the Impairment of Energy Metabolism Induced by Aβ Peptides on PC12 Cells: Protection by Antioxidants , 1999, Neurobiology of Disease.

[65]  D. Hinton,et al.  Apoptosis in surgically excised choroidal neovascular membranes in age-related macular degeneration. , 1998, Archives of ophthalmology.

[66]  C. Thompson,et al.  Apoptosis in the pathogenesis and treatment of disease , 1995, Science.

[67]  L. Kolonel Fat and Cancer , 1997 .

[68]  G. D. De Meyer,et al.  Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. , 1998, Circulation research.

[69]  T Gasser,et al.  Phenotypic expression of the DYT1 mutation: A family with writer's cramp of juvenile onset , 1998, Annals of neurology.

[70]  A. Kong,et al.  Molecular Mechanisms of c-Jun N-terminal Kinase-mediated Apoptosis Induced by Anticarcinogenic Isothiocyanates* , 1998, The Journal of Biological Chemistry.

[71]  R E Burke,et al.  Apoptosis in neurodegenerative disorders. , 1997, Current opinion in neurology.

[72]  R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[73]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[74]  M. Peter,et al.  Apoptosis signaling in lymphocytes. , 1999, Current opinion in immunology.

[75]  Dirk Bohmann,et al.  Diverse functions of JNK signaling and c-Jun in stress response and apoptosis , 1999, Oncogene.

[76]  D. Geschwind,et al.  The apolipoprotein E ε4 allele is not a significant risk factor for frontotemporal dementia , 1998 .

[77]  A. Constantinou,et al.  Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells. , 1998, European journal of cancer.

[78]  P. Shah Plaque disruption and thrombosis: potential role of inflammation and infection. , 1999, Cardiology in review.

[79]  G M Cohen,et al.  Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.

[80]  W. Tatton,et al.  Mitochondria in neurodegenerative apoptosis: An opportunity for therapy? , 1998, Annals of neurology.

[81]  M. Gould Cancer chemoprevention and therapy by monoterpenes. , 1997, Environmental health perspectives.

[82]  M. Gelb,et al.  Protein prenylation: from discovery to prospects for cancer treatment. , 1998, Current opinion in chemical biology.

[83]  F. Levi Cancer prevention: epidemiology and perspectives. , 1999, European journal of cancer.

[84]  M. Bennett Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. , 1999, Cardiovascular research.

[85]  Andrew Davis 8. Reliability, Validity and Criterion-referencing , 1998 .

[86]  Dean P. Jones,et al.  Apoptosis: Cell death defined by caspase activation , 1999, Cell Death and Differentiation.

[87]  Z. Shao,et al.  Genistein inhibits proliferation similarly in estrogen receptor‐positive and negative human breast carcinoma cell lines characterized by P21WAF1/CIP1 induction, G2/M arrest, and apoptosis , 1998, Journal of cellular biochemistry.

[88]  T. Sugimura,et al.  Effects of a Soybean Isoflavone Mixture on Carcinogenesis in Prostate and Seminal Vesicles of F344 Rats , 1999, Japanese journal of cancer research : Gann.